Stanrose Mafat. (506105)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹84 |
| Market Cap | ₹34.14 Cr |
| P/E Ratio | 0 |
| ROCE | -4.69% |
| ROE | -5.69% |
| Dividend Yield | 0% |
| Profit Growth | -1.15% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹54.31 — ₹84 |
| Sector | Finance |
| Book Value | ₹131.25 |
Strengths
- Trades at a 36% discount to book value of ₹131.25 per share
- Price-to-book of 0.64 provides a potential margin of safety if assets are sound
- Small market cap of ₹34 Cr allows room for value-unlocking events
- Recent price near 52-week high suggests some investor interest
Concerns
- Negative ROE of -5.69% and ROCE of -4.69% indicate value destruction
- Piotroski F-score of 2/9 points to weak financial health
- Latest quarter shows net loss of ₹1 Cr on sales of just ₹1 Cr
- No dividend and stagnant sales with declining profit growth
AI Analysis
Stanrose Mafat presents an interesting but troubling puzzle. The market capitalises the company at just ₹34 Cr, while the book value stands at ₹131.25 per share. That puts the price at a 36% discount to stated net worth. In Graham's language, that is a margin of safety. But as an investment company, the worth of the balance sheet depends entirely on the quality and liquidity of its assets. The figures I see do not comfort me. Return on equity is -5.69%, and ROCE is -4.69%. The latest quarter saw sales of ₹1 Cr and a net loss of ₹1 Cr. Profit growth has declined further by 1.15%. This is a business destroying value, not creating it. The Piotroski F-score of 2 out of 9 is a red flag. It suggests deteriorating fundamentals, weak profitability, and possibly stressed working capital. There is no dividend to reward patience. I do not see a moat here; this is a shell or a holding company whose assets must be assessed item by item. A low P/B is only a good sign if the book value is real and recoverable. I would need to see the investment portfolio, the marketable securities, and any hidden liabilities. The fact that debt-to-equity is not available reminds me to be even more sceptical. Without earnings power, I should not rely on book value alone. At the right price, it could be an asset play. But at ₹84, near the 52-week high, I would rather wait for a deeper discount or event that unlocks value. For now, this is a cautious pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer